Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance

Peter Nash, Philip J. Mease, Dona Fleishaker, Joseph Wu, Laura C. Coates, Frank Behrens, Dafna D. Gladman, Alan Kivitz, James Cheng‐Chung Wei, I. V. Shirinsky, Sujatha Menon, Ana Belén Romero, Lara Fallon, Ming‐Ann Hsu, Cunshan Wang, Keith S. Kanik